PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24225P1431Gene expression reagents — 10x Genomics, Inc

10x Genomics, Inc holds $22.3M across 424 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 9, 2028 PoP end — agencies typically plan 12–18 months ahead.

242-Network Contract Office 02 (36C242)

Awarding office

10x Genomics, Inc

Recipient

Sep 9, 2028

PoP end

$475K

Obligated

$699K

Potential

325413

NAICS

6550

PSC

Unrestricted

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted

Contract number36C24225P1431

Also listed as36C242-25-P-1431

Agency242-Network Contract Office 02 (36C242)

Awarding office242-Network Contract Office 02 (36C242)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

Incumbent10x Genomics, Inc

CAGE7EWK7

UEID1NLDEZ14TV5

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Place of performancePLEASANTON CA

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

Related solicitation36C24225Q0867

PoP startSep 10, 2025

PoP end (current)Sep 9, 2028

Obligated$475K

Current value$475K

Potential value$699K

Gene Expression Reagents is a federal Unrestricted award for 242-Network Contract Office 02 (36C242) held by 10x Genomics, Inc. Estimated value $699K ($475K obligated). Current period of performance ends Sep 9, 2028. Last award drew 1 bidder. Place of performance: PLEASANTON CA. Related solicitation 36C24225Q0867.

Gene expression reagents. Latest action is a modification.

Recompete timing

Public

● Expiring in 690 days

Current PoP ends Sep 9, 2028 (690 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 9, 2027.

Want the durability read on 36C24225P1431? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

10x Genomics, Inc — $22.3M obligated across 424 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($22.3M) · all agencies

Department of Health and Human Services (HHS)$17.4M · 78%Department of Veterans Affairs (VA)$2.3M · 10%Department of Defense (DOD)$2.2M · 10%Department of Agriculture (USDA)$350K · 2%

Open full company profile →

Related awards

Same incumbent

75N98026P01435

NIAMS: SUPPLY: 10X GENOMICS ATERA PLATFORM: N/A

$560K

Oct 27, 2026

75N95B26P00042

NIMH: SUPPLY: DIAGNOSTIC LABORATORY EQUIPMENT: N/A FOR THE HBCC SINGLE-NUCLEUS SEQUENCING …

$301K

Dec 31, 2026

75N98026P01778

NHGRI - GEM-X UNIVERSAL 5 GENE EXPRESSION

$120K

Mar 31, 2027

75D30123P16486

10X GENOMICS - IMMUN

$105K

Jun 12, 2027

36C24126P0349

10X GENOMICS TEST KITS

$350K

Jun 14, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24225P1431?

36C24225P1431 (Gene expression reagents) is a 242-Network Contract Office 02 (36C242) award with a potential value of $699K, currently held by 10x Genomics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-25-P-1431?

36C242-25-P-1431 is the dashed form of PIID 36C24225P1431 (Gene expression reagents), held by 10x Genomics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24225P1431?

242-Network Contract Office 02 (36C242) awarded 36C24225P1431 to 10x Genomics, Inc (potential $699K).

Who is the incumbent on 36C24225P1431?

10x Genomics, Inc is the incumbent with $22.3M across 424 related awards in SCOUT’s public footprint. The current period of performance ends Sep 9, 2028.

When does 10x Genomics, Inc’s 36C24225P1431 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 9, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24225P1431? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 9, 2026